Onco Wiki / Indication

Mycosis Fungoides / Sézary Syndrome · line 2 · Bexarotene PO monotherapy for CTCL (300 mg/m² daily, continuous)

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Notes

STUB. Major UA access barrier — international supply required. Topical 1% gel useful for limited disease (compounding sometimes available domestically). Maintenance dose continuation in responders is standard.

Used By

Algorithms

• ALGO-MF-SEZARY-2L - ALGO-MF-SEZARY-2L